Evidence map›Paper›PMID 42020503›Full record

ArticleNPJ digital medicine2026

Evaluation of causal reasoning for large language models in contextualized clinical scenarios of laboratory test interpretation.

Balu Bhasuran, Mattia Prosperi, Karim Hanna, John Petrilli, Caretia JeLayne Washington, Zhe He

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Balu BhasuranSchool of Information, Florida State University, Tallahassee, FL, USA.
Mattia ProsperiDepartment of Epidemiology, University of Florida, Gainesville, FL, USA.
Karim HannaMorsani College of Medicine, University of South Florida, Tampa, FL, USA.
John PetrilliMorsani College of Medicine, University of South Florida, Tampa, FL, USA.
Caretia JeLayne WashingtonDepartment of Epidemiology, University of Florida, Gainesville, FL, USA.
Zhe HeSchool of Information, Florida State University, Tallahassee, FL, USA. zhe@fsu.edu.

Funding

Technology Identification and Training CoreP30AG073105 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DEMIRIS, GEORGE, KARLAWISH, JASON H · 2021 to 2025
$21.2M
INSiGHTS - Innovative Next Steps in Gaining Health Improvements Through Translational ScienceUM1TR005128 · NCATS · UNIVERSITY OF FLORIDA · PI DUANE A. MITCHELL, SYLVIE NAAR · 2025 to 2026
$10.7M
Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)R01AI172875 · NIAID · UNIVERSITY OF FLORIDA · PI Jiang Bian, Mattia Prosperi · 2023 to 2026
$2.8M
AHRQ HHS R21 HS029969AHRQ HHS R21HS029969NCATS NIH HHS UM1 TR005128NCATS NIH HHS UM1TR005128NIAID NIH HHS R01 AI172875NIA NIH HHS P30 AG073105NIA NIH HHS P30AG073105
6 · The paper itself

Abstract

This study evaluates causal reasoning in large language models (LLMs) using 99 clinically grounded laboratory test scenarios mapped to Pearl's Ladder of Causation: association, intervention, and counterfactual reasoning. We focused on common lab tests such as Hemoglobin A1c (HbA1c), creatinine, and vitamin D, and paired them with clinically relevant causal factors, including age, gender, obesity, and smoking. Two LLMs, GPT-o1 and Llama-3.2-8b-instruct, were tested, with responses rated by four medically trained human experts. GPT-o1 demonstrated superior discriminative performance (AUROC overall = 0.80 ± 0.12) compared to Llama-3.2-8b-instruct (0.73 ± 0.15), with higher association (0.75 vs. 0.72), intervention (0.84 vs. 0.70), and counterfactual scores (0.84 vs. 0.69). Sensitivity (0.90 vs. 0.84) and specificity (0.70 vs. 0.62) were also greater for GPT-o1. Reasoning ratings followed similar trends. Both models performed best on intervention questions and worst on counterfactuals, particularly "altered outcome" scenarios. Findings suggest GPT-o1 offers more consistent causal reasoning, but further refinement is needed before high-stakes clinical deployment.

Identifiers

PMID42020503
PMCPMC13315323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.